<VariationArchive VariationID="8733" VariationName="NM_000182.5(HADHA):c.2132dup (p.Pro712fs)" VariationType="Duplication" Accession="VCV000008733" Version="13" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-15" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="23772" VariationID="8733">
      <GeneList>
        <Gene Symbol="GAREM2" FullName="GRB2 associated regulator of MAPK1 subtype 2" GeneID="150946" HGNC_ID="HGNC:27172" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="26173088" stop="26204304" display_start="26173088" display_stop="26204304" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="26395959" stop="26412531" display_start="26395959" display_stop="26412531" Strand="+" />
          </Location>
          <OMIM>617999</OMIM>
        </Gene>
        <Gene Symbol="HADHA" FullName="hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha" GeneID="3030" HGNC_ID="HGNC:4801" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="26190635" stop="26244632" display_start="26190635" display_stop="26244632" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="26413503" stop="26467593" display_start="26413503" display_stop="26467593" Strand="-" />
          </Location>
          <OMIM>600890</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000182.5(HADHA):c.2132dup (p.Pro712fs)</Name>
      <CanonicalSPDI>NC_000002.12:26191496:GGG:GGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="26191496" stop="26191497" display_start="26191496" display_stop="26191497" variantLength="1" positionVCF="26191496" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="26414365" stop="26414366" display_start="26414365" display_stop="26414366" variantLength="1" positionVCF="26414365" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>P712fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.26414368dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.26414368dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.26191499dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.26191499dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007121.1" sequenceAccession="NG_007121" sequenceVersion="1" change="g.58124dup">
            <Expression>NG_007121.1:g.58124dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000182.5" sequenceAccession="NM_000182" sequenceVersion="5" change="c.2132dup" MANESelect="true">
            <Expression>NM_000182.5:c.2132dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000173.2" sequenceAccession="NP_000173" sequenceVersion="2" change="p.Pro712fs">
            <Expression>NP_000173.2:p.Pro712fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_747t1" sequenceAccession="LRG_747t1">
            <Expression>LRG_747t1:c.2132dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_747p1" sequenceAccession="LRG_747p1" change="p.Pro712fs">
            <Expression>LRG_747p1:p.Pro712fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600890.0006" DB="OMIM" />
        <XRef Type="rs" ID="1574600309" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000182.5(HADHA):c.2132dup (p.Pro712fs) AND Mitochondrial trifunctional protein deficiency" Accession="RCV000009272" Version="3">
        <ClassifiedConditionList TraitSetID="2402">
          <ClassifiedCondition DB="MedGen" ID="C1969443">Mitochondrial trifunctional protein deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000182.5(HADHA):c.2132dup (p.Pro712fs) AND not provided" Accession="RCV003311654" Version="9">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000182.5(HADHA):c.2132dup (p.Pro712fs) AND multiple conditions" Accession="RCV003764540" Version="2">
        <ClassifiedConditionList TraitSetID="39862">
          <ClassifiedCondition DB="MedGen" ID="C3711645">Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1969443">Mitochondrial trifunctional protein deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000182.5(HADHA):c.2132dup (p.Pro712fs) AND Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency" Accession="RCV003466842" Version="2">
        <ClassifiedConditionList TraitSetID="6645">
          <ClassifiedCondition DB="MedGen" ID="C3711645">Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-08" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9266371</ID>
        </Citation>
        <DescriptionHistory Dated="2023-12-29">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2023-07-11">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="39862" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15869" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deficiency of long-chain 3-hydroxyacyl-coenzyme A dehydrogenase</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0012173" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LCHAD Deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and trifunctional protein (TFP) deficiency are caused by impairment of mitochondrial TFP. TFP has three enzymatic activities – long-chain enoyl-CoA hydratase, long-chain 3-hydroxyacyl-CoA dehydrogenase, and long-chain 3-ketoacyl-CoA thiolase. In individuals with LCHAD deficiency, there is isolated deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase, while deficiency of all three enzymes occurs in individuals with TFP deficiency. Individuals with TFP deficiency can present with a severe-to-mild phenotype, while individuals with LCHAD deficiency typically present with a severe-to-intermediate phenotype. Neonates with the severe phenotype present within a few days of birth with hypoglycemia, hepatomegaly, encephalopathy, and often cardiomyopathy. The intermediate phenotype is characterized by hypoketotic hypoglycemia precipitated by infection or fasting in infancy. The mild (late-onset) phenotype is characterized by myopathy and/or neuropathy. Long-term complications include peripheral neuropathy and retinopathy.</Attribute>
                <XRef ID="NBK583531" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6867" />
                <XRef ID="6867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36063482</ID>
                <ID Source="BookShelf">NBK583531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-OH-C18-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, LCHAD/TFP: C16-OH Elevated +/-C18-OH, 2022</CitationText>
              </Citation>
              <XRef ID="5" DB="Orphanet" />
              <XRef ID="C3711645" DB="MedGen" />
              <XRef ID="MONDO:0012173" DB="MONDO" />
              <XRef Type="MIM" ID="609016" DB="OMIM" />
            </Trait>
            <Trait ID="9419" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mitochondrial trifunctional protein deficiency</ElementValue>
                <XRef ID="MONDO:0012172" DB="MONDO" />
                <XRef ID="237999008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TFP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3684" />
                <XRef ID="3684" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and trifunctional protein (TFP) deficiency are caused by impairment of mitochondrial TFP. TFP has three enzymatic activities – long-chain enoyl-CoA hydratase, long-chain 3-hydroxyacyl-CoA dehydrogenase, and long-chain 3-ketoacyl-CoA thiolase. In individuals with LCHAD deficiency, there is isolated deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase, while deficiency of all three enzymes occurs in individuals with TFP deficiency. Individuals with TFP deficiency can present with a severe-to-mild phenotype, while individuals with LCHAD deficiency typically present with a severe-to-intermediate phenotype. Neonates with the severe phenotype present within a few days of birth with hypoglycemia, hepatomegaly, encephalopathy, and often cardiomyopathy. The intermediate phenotype is characterized by hypoketotic hypoglycemia precipitated by infection or fasting in infancy. The mild (late-onset) phenotype is characterized by myopathy and/or neuropathy. Long-term complications include peripheral neuropathy and retinopathy.</Attribute>
                <XRef ID="NBK583531" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36063482</ID>
                <ID Source="BookShelf">NBK583531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-OH-C18-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, LCHAD/TFP: C16-OH Elevated +/-C18-OH, 2022</CitationText>
              </Citation>
              <XRef ID="746" DB="Orphanet" />
              <XRef ID="C1969443" DB="MedGen" />
              <XRef ID="MONDO:0012172" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS609015" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6645" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15869" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deficiency of long-chain 3-hydroxyacyl-coenzyme A dehydrogenase</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0012173" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LCHAD Deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and trifunctional protein (TFP) deficiency are caused by impairment of mitochondrial TFP. TFP has three enzymatic activities – long-chain enoyl-CoA hydratase, long-chain 3-hydroxyacyl-CoA dehydrogenase, and long-chain 3-ketoacyl-CoA thiolase. In individuals with LCHAD deficiency, there is isolated deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase, while deficiency of all three enzymes occurs in individuals with TFP deficiency. Individuals with TFP deficiency can present with a severe-to-mild phenotype, while individuals with LCHAD deficiency typically present with a severe-to-intermediate phenotype. Neonates with the severe phenotype present within a few days of birth with hypoglycemia, hepatomegaly, encephalopathy, and often cardiomyopathy. The intermediate phenotype is characterized by hypoketotic hypoglycemia precipitated by infection or fasting in infancy. The mild (late-onset) phenotype is characterized by myopathy and/or neuropathy. Long-term complications include peripheral neuropathy and retinopathy.</Attribute>
                <XRef ID="NBK583531" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6867" />
                <XRef ID="6867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36063482</ID>
                <ID Source="BookShelf">NBK583531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-OH-C18-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, LCHAD/TFP: C16-OH Elevated +/-C18-OH, 2022</CitationText>
              </Citation>
              <XRef ID="5" DB="Orphanet" />
              <XRef ID="C3711645" DB="MedGen" />
              <XRef ID="MONDO:0012173" DB="MONDO" />
              <XRef Type="MIM" ID="609016" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2402" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9419" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mitochondrial trifunctional protein deficiency</ElementValue>
                <XRef ID="MONDO:0012172" DB="MONDO" />
                <XRef ID="237999008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TFP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3684" />
                <XRef ID="3684" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and trifunctional protein (TFP) deficiency are caused by impairment of mitochondrial TFP. TFP has three enzymatic activities – long-chain enoyl-CoA hydratase, long-chain 3-hydroxyacyl-CoA dehydrogenase, and long-chain 3-ketoacyl-CoA thiolase. In individuals with LCHAD deficiency, there is isolated deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase, while deficiency of all three enzymes occurs in individuals with TFP deficiency. Individuals with TFP deficiency can present with a severe-to-mild phenotype, while individuals with LCHAD deficiency typically present with a severe-to-intermediate phenotype. Neonates with the severe phenotype present within a few days of birth with hypoglycemia, hepatomegaly, encephalopathy, and often cardiomyopathy. The intermediate phenotype is characterized by hypoketotic hypoglycemia precipitated by infection or fasting in infancy. The mild (late-onset) phenotype is characterized by myopathy and/or neuropathy. Long-term complications include peripheral neuropathy and retinopathy.</Attribute>
                <XRef ID="NBK583531" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36063482</ID>
                <ID Source="BookShelf">NBK583531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-OH-C18-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, LCHAD/TFP: C16-OH Elevated +/-C18-OH, 2022</CitationText>
              </Citation>
              <XRef ID="746" DB="Orphanet" />
              <XRef ID="C1969443" DB="MedGen" />
              <XRef ID="MONDO:0012172" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS609015" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="29490" SubmissionDate="2010-11-10" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600890.0006_LCHAD DEFICIENCY" title="HADHA, 1-BP INS, 2129C_LCHAD DEFICIENCY" />
        <ClinVarAccession Accession="SCV000029490" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Most patients with a defect in the mitochondrial trifunctional protein complex have an isolated deficiency of LCHAD activity (609016). In a group of 46 LCHAD-deficient patients studied enzymatically, IJlst et al. (1997) found 12 to be compound heterozygous for the common 1528G-C mutation (600890.0001) and another mutation in HADHA. IJlst et al. (1997) described 2 new mutations found in this compound heterozygous group. One was an insertion of a C at position 2129, changing the reading frame for the alpha subunit and creating a premature stop codon at residue 733, resulting in a truncated protein that was presumed to be unstable. The second was a 1025T-C transition, resulting in a leu342-to-pro (L342P; 600890.0007) substitution.</Attribute>
              <Citation>
                <ID Source="PubMed">9266371</ID>
              </Citation>
              <XRef DB="OMIM" ID="609016" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HADHA" />
          </GeneList>
          <Name>HADHA, 1-BP INS, 2129C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 2129C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600890.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LCHAD DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7507286" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2023-07-16">
        <ClinVarSubmissionID localKey="131186|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004011131" DateUpdated="2024-07-15" DateCreated="2023-07-16" Type="SCV" Version="9" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>HADHA: PVS1:Strong, PM2, PM3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HADHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="CG" referenceAllele="C" start="26414365" stop="26414365" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8525556" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="4826922|MedGen:C1969443;CN074230" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004569556" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9266371</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro712Alafs*26) in the HADHA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 52 amino acid(s) of the HADHA protein. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the HADHA protein in which other variant(s) (p.Thr745Serfs*8) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 8733). This variant is also known as Phe-710‚Üístop733. This premature translational stop signal has been observed in individual(s) with HADHA-related conditions (PMID: 9266371). This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HADHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.26414365_26414366insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1969443" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN074230" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7847444" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000182.5:c.2132dup|OMIM:609016" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004191793" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000182.5:c.2132dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609016" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="29490" TraitType="Disease" MappingType="Name" MappingValue="LCHAD DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C3711645" Name="Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7507286" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8525556" TraitType="Disease" MappingType="XRef" MappingValue="CN074230" MappingRef="MedGen">
        <MedGen CUI="C3711645" Name="Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8525556" TraitType="Disease" MappingType="XRef" MappingValue="C1969443" MappingRef="MedGen">
        <MedGen CUI="C1969443" Name="Mitochondrial trifunctional protein deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7847444" TraitType="Disease" MappingType="XRef" MappingValue="609016" MappingRef="OMIM">
        <MedGen CUI="C3711645" Name="Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

